Stimcell Energetics (STME) Cash & Equivalents (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -77.78% |
| Nov 30, 2025 | 617.09% |
| Aug 31, 2025 | -55.85% |
| May 31, 2025 | 118.34% |
| Feb 28, 2025 | -80.25% |
| Nov 30, 2024 | 64.56% |
| Aug 31, 2024 | -52.66% |
| May 31, 2024 | -45.51% |
| Feb 29, 2024 | 252.19% |
| Nov 30, 2023 | -61.04% |
| Aug 31, 2023 | -40.92% |
| May 31, 2023 | 1,188.61% |
| Feb 28, 2023 | -57.18% |
| Nov 30, 2022 | 85.17% |
| Aug 31, 2022 | -60.54% |
| May 31, 2022 | -20.68% |
| Feb 28, 2022 | -17.26% |
| Nov 30, 2021 | -41.75% |
| Aug 31, 2021 | 207.29% |
| May 31, 2021 | -20.08% |
| Feb 28, 2021 | 19.20% |
| Nov 30, 2020 | -81.92% |
| Aug 31, 2020 | 167.19% |
| May 31, 2020 | -60.12% |
| Feb 29, 2020 | -58.88% |
| Nov 30, 2019 | -22.03% |
| Aug 31, 2019 | 516.86% |
| May 31, 2019 | -56.31% |
| Feb 28, 2019 | 436.82% |
| Nov 30, 2018 | 78.16% |
| Aug 31, 2018 | 66.87% |
| May 31, 2018 | -65.90% |
| Feb 28, 2018 | -77.81% |
| Nov 30, 2017 | -66.76% |
| Aug 31, 2017 | 383.06% |
| May 31, 2017 | 638.45% |
| Feb 28, 2017 | -92.25% |
| Nov 30, 2016 | 210.83% |
| Aug 31, 2016 | 37.72% |
| May 31, 2016 | 86.29% |